Sign in

CIK 0000886744

  • Large accelerated filer
Ticker
GERN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
752287752
Phone
+1 650-473-7700
Business address
919 EAST HILLSDALE BOULEVARD, SUITE 250, FOSTER CITY, CA, 94404
Former names
GERON CORPORATION
Open-market buys, last 90 days
$62,105
in 2 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$62,105. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Semerjian Harout +$51K President & CEO 1 filing
  2. Williams Timothy +$11K EVP and Chief Legal Officer 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-11-16 Williams Timothy EVP and Chief Legal Officer Purchase +12,000 $0.94 $11K 12,000
2026-11-13 Semerjian Harout President & CEO Purchase +53,500 $0.95 $51K 53,500
2026-09-30 Spiegel Robert J. Director Grant or award +6,351 $1.23 $8K 212,161
2026-06-30 Spiegel Robert J. Director Grant or award +6,103 $1.28 $8K 205,810
2026-05-20 McDonald John F Director Grant or award · Stock Option (right to buy) +220,000 220,000
2026-05-20 O'Farrell Elizabeth G. Director Grant or award · Stock Option (right to buy) +220,000 220,000
2026-05-20 Bir Dawn Carter Director Grant or award · Stock Option (right to buy) +220,000 220,000
2026-05-20 Molineaux Susan Director Grant or award · Stock Option (right to buy) +220,000 220,000
2026-05-20 Spiegel Robert J. Director Grant or award · Stock Option (right to buy) +220,000 220,000
2026-04-13 Williams Timothy EVP and Chief Legal Officer Grant or award · Stock Option (Right to Buy) +2,500,000 2,500,000
2026-03-31 Spiegel Robert J. Director Grant or award +5,243 $1.49 $8K 199,707
2026-03-25 Chinoporos Constantine Director Grant or award · Stock Option (Right to Buy) +270,000 270,000
2026-03-25 Andrews Patricia S Director Grant or award · Stock Option (Right to Buy) +270,000 270,000
2026-02-18 ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER Option exercise +27,500 27,500
2026-02-18 ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER Sale −9,855 $1.94 $19K 17,645
2026-02-18 ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER Option exercise · Restricted Stock Units −27,500 82,500
2026-02-17 Eid Joseph EVP, R&D; Chief Medical Office Grant or award · Stock Option (Right to Buy) +2,220,000 2,220,000
2026-02-17 ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER Grant or award · Stock Option (Right to Buy) +1,660,000 1,660,000
2025-12-31 Spiegel Robert J. Director Grant or award +5,918 $1.32 $8K 194,464
2025-10-20 ElNawawi Ahmed EVP, Chief Commercial Officer Grant or award · Stock Option (right to buy) +3,000,000 3,000,000

Page 1 of 15 · 291 trades